SEC Form 3 · accession 0001514346-15-000001
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Kathleen Bielasz
Officer — VP, Accounting & Controller
Period of report
Jul 10, 2015
Accepted (ET)
Jul 13, 2015 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 4,256 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $16.80 | holding | — | — | — | — | Jan 20, 2016 | Common Stock | 3,000 | — | D |
| Employee Stock Option (right to buy)F2 | $10.52 | holding | — | — | — | — | Jul 28, 2016 | Common Stock | 4,000 | — | D |
| Employee Stock Option (right to buy)F3 | $13.50 | holding | — | — | — | — | Feb 26, 2017 | Common Stock | 6,500 | — | D |
| Employee Stock Option (right to buy)F4 | $4.01 | holding | — | — | — | — | Mar 17, 2019 | Common Stock | 3,000 | — | D |
| Employee Stock Option (right to buy)F5 | $3.25 | holding | — | — | — | — | Mar 17, 2020 | Common Stock | 4,500 | — | D |
| Employee Stock Option (right to buy)F6 | $1.81 | holding | — | — | — | — | Mar 19, 2022 | Common Stock | 10,000 | — | D |
| Employee Stock Option (right to buy)F7 | $8.54 | holding | — | — | — | — | Mar 5, 2020 | Common Stock | 24,000 | — | D |
| Employee Stock Option (right to buy)F8 | $6.80 | holding | — | — | — | — | Mar 3, 2021 | Common Stock | 40,000 | — | D |
| Employee Stock Option (right to buy)F9 | $4.47 | holding | — | — | — | — | Mar 11, 2022 | Common Stock | 60,000 | — | D |
Explanation of responses
- F1The options vested and became exercisable in four equal annual installments beginning on January 20, 2007.
- F2The options vested and became exercisable in four equal annual installments beginning on July 28, 2007.
- F3The options vested and became exercisable in four equal annual installments beginning on February 26, 2008.
- F4The options originally for a total of 6,000 shares vested and became exercisable in four equal annual installments beginning on March 17, 2010.
- F5The options originally for a total of 9,000 shares vested and became exercisable in four equal annual installments beginning on March 17, 2011.
- F6The options originally for a total of 40,000 shares vest in four equal annual installments, and are exercisable once vested. The first installment became exercisable on March 19, 2013, the second installment became exercisable on March 19, 2014, the third installment became exercisable on March 19, 2015, and the fourth installment vests on March 19, 2016.
- F7The options vest in four equal annual installments, and are exercisable once vested. The first installment became exercisable on March 5, 2014, the second installment became exercisable on March 5, 2015, the third installment vests on March 5, 2016, and the fourth installment vests on March 5, 2017.
- F8The options vest in four equal annual installments, and are exercisable once vested. The first installment became exercisable on March 3, 2015, the second installment vests on March 3, 2016, the third installment vests on March 3, 2017, and the fourth installment vests on March 3, 2018.
- F9The options vest in four equal annual installments beginning on March 11, 2016, and are exercisable once vested.